Prediction of Human Pharmacokinetic Profile After Transdermal Drug Application Using Excised Human Skin

被引:13
作者
Yamamoto, Syunsuke [1 ]
Karashima, Masatoshi [2 ]
Arai, Yuta [2 ]
Tohyama, Kimio [1 ]
Amano, Nobuyuki [1 ]
机构
[1] Takeda Pharmaceut Co Ltd, Drug Metab & Pharmacokinet Res Labs, 26-1 Muraoka Higashi 2-Chome, Fujisawa, Kanagawa, Japan
[2] Takeda Pharmaceut Co Ltd, Analyt Dev Pharmaceut Sci, 26-1 Muraoka Higashi 2-Chome, Fujisawa, Kanagawa, Japan
关键词
absorption; in vitro/in vivo correlations; mathematical model; pharmacokinetics; skin; transdermal; INVITRO PERCUTANEOUS-ABSORPTION; PIG EAR; PERMEABILITY; PENETRATION; PERMEATION; KINETICS;
D O I
10.1016/j.xphs.2017.03.003
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Although several mathematical models have been reported for the estimation of human plasma concentration profiles of drug substances after dermal application, the successful cases that can predict human pharmacokinetic profiles are limited. Therefore, the aim of this study is to investigate the prediction of human plasma concentrations after dermal application using in vitro permeation parameters obtained from excised human skin. The in vitro skin permeability of 7 marketed drug products was evaluated. The plasma concentration-time profiles of the drug substances in humans after their dermal application were simulated using compartment models and the clinical pharmacokinetic parameters. The transdermal process was simulated using the in vitro skin permeation rate and lag time assuming a zero-order absorption. These simulated plasma concentration profiles were compared with the clinical data. The result revealed that the steady-state plasma concentration of diclofenac and the maximum concentrations of nicotine, bisoprolol, rivastigmine, and lidocaine after topical application were within 2-fold of the clinical data. Furthermore, the simulated concentration profiles of bisoprolol, nicotine, and rivastigmine reproduced the decrease in absorption due to drug depletion from the formulation. In conclusion, this simple compartment model using in vitro human skin permeation parameters as zero-order absorption predicted the human plasma concentrations accurately. (C) 2017 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:2787 / 2794
页数:8
相关论文
共 39 条
  • [1] [Anonymous], PHARM MED DEV AG
  • [2] [Anonymous], DRUGS INT FOR BIS TA
  • [3] Pig and guinea pig skin as surrogates for human in vitro penetration studies: A quantitative review
    Barbero, Ana M.
    Frasch, H. Frederick
    [J]. TOXICOLOGY IN VITRO, 2009, 23 (01) : 1 - 13
  • [4] STABLE ISOTOPE STUDIES OF NICOTINE KINETICS AND BIOAVAILABILITY
    BENOWITZ, NL
    JACOB, P
    DENARO, C
    JENKINS, R
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (03) : 270 - 277
  • [5] METHODS FOR INVITRO PERCUTANEOUS-ABSORPTION STUDIES .6. PREPARATION OF THE BARRIER LAYER
    BRONAUGH, RL
    STEWART, RF
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (05) : 487 - 491
  • [6] PHARMACOKINETICS OF DRUG PERMEATION THROUGH HUMAN-SKIN
    CHANDRASEKARAN, SK
    BAYNE, W
    SHAW, JE
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (10) : 1370 - 1374
  • [7] In Silico Prediction of Percutaneous Absorption and Disposition Kinetics of Chemicals
    Chen, Longjian
    Han, Lujia
    Saib, Ouarda
    Lian, Guoping
    [J]. PHARMACEUTICAL RESEARCH, 2015, 32 (05) : 1779 - 1793
  • [8] Recent advances in predicting skin permeability of hydrophilic solutes
    Chen, Longjian
    Han, Lujia
    Lian, Guoping
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (02) : 295 - 305
  • [9] Comparative in vitro-in vivo percutaneous penetration of the fungicide ortho-phenylphenol
    Cnubben, NHP
    Elliott, GR
    Hakkert, BC
    Meuling, WJA
    van de Sandt, JJM
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2002, 35 (02) : 198 - 208
  • [10] Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure
    Dancik, Yuri
    Miller, Matthew A.
    Jaworska, Joanna
    Kasting, Gerald B.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (02) : 221 - 236